Unveiling the NEFH+ malignant cell subtype: Insights from single-cell RNA sequencing in prostate cancer progression and tumor microenvironment interactions
BackgroundProstate cancer (PCa) is a multifactorial and heterogeneous disease, ranking among the most prevalent malignancies in men. In 2020, there were 1,414,259 new cases of PCa worldwide, accounting for 7.3% of all malignant tumors. The incidence rate of PCa ranks third, following breast cancer a...
        Saved in:
      
    
          | Main Authors: | Jie Wang, Fu Zhao, Qiang Zhang, Zhou Sun, Zhikai Xiahou, Changzhong Wang, Yan Liu, Zongze Yu | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Frontiers Media S.A.
    
        2024-12-01 | 
| Series: | Frontiers in Immunology | 
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1517679/full | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Spatially-resolved analyses of muscle invasive bladder cancer microenvironment unveil a distinct fibroblast cluster associated with prognosis        
                          
 by: Chao Feng, et al.
 Published: (2024-12-01)
- 
                
                    Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume II        
                          
 by: Xu-jie Zhou, et al.
 Published: (2025-01-01)
- 
                
                    Cancer phenomics research hotspots and development trends: a bibliometric analysis from 2000 to 2023        
                          
 by: Shupeng Chen, et al.
 Published: (2024-12-01)
- 
                
                    The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia        
                          
 by: QIAN Xinhang, et al.
 Published: (2024-02-01)
- 
                
                    Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer        
                          
 by: Jiani Wu, et al.
 Published: (2024-12-01)
 
       